Author:
Soria J.-C.,Fayette J.,Armand J.-P.
Reference38 articles.
1. Angiogenesis: pathological, prognostic, and growth-factor pathways and their link to trial design and anticancer drugs;Fox;Lancet Oncol,2001
2. Clinical translation of angiogenesis inhibitors;Kerbel;Nat Rev Cancer,2002
3. A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer;Yang;N Engl J Med,2003
4. Bevacizumab (B) plus gemcitabine (G) in patients (PTS) with advanced pancreatic cancer (PC);Kindler;Proc Am Soc Clin Oncol,2003
5. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer;Hurwitz;N Engl J Med,2004
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献